Amy Lerman

Amy Lerman is a Member of Epstein Becker Green’s Health Care and Life Sciences team and is based in the firm’s Washington, DC office. Amy advises a wide range of clients—including durable medical equipment (DME) suppliers, digital health companies, and other health care innovators—on complex legal, regulatory, and compliance matters.  Amy counsels clients on government investigations, audits, and allegations involving fraud, false claims, and related compliance risks. She provides guidance on a broad scope of regulatory questions and helps clients develop and strengthen corporate compliance program infrastructures. Clients regularly turn to Amy for insight into legal and reimbursement issues under Medicare, Medicaid, and other third-party payer programs.

Amy is particularly focused on supporting companies navigating phases of innovation, growth, and operational evolution. She helps emerging and disruptive health care companies align their business models with the evolving regulatory landscape and anticipate policy shifts. In addition, Amy is the lead author of the firm’s Telemental Health Laws app, a comprehensive survey of state telehealth laws, regulations, and policies for mental and behavioral health practitioners and stakeholders across all 50 states, the District of Columbia, and Puerto Rico.